Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Updated version of the disease management program “Coronary heart disease” was released by the Institute for Quality and Efficiency in Health Care (IQWiG) in March of 2018

02 May 2018

At the end of March of 2018, the Institute for Quality and Efficiency in Health Care (IQWiG) has released an updated version of the disease management program (DMP) “Coronary heart disease”, which was initially implemented in 2003. According to §137f SGB V, the Federal Joint Committee (G-BA) has to conduct the selection of relevant chronic illnesses for DMPs, define the requirements for these programs and provide their regular update. Thus, in order to adapt DMP to the current state of medical knowledge, its updating process was initiated by the Federal Joint Committee (G-BA). The IQWiG has provided a search for current evidence-based clinical practice guidelines on coronary heart disease (CHD), summarized the recommendations in key statements, and checked whether these resulted in a need for updating has commissioned. According to the obtained results, there was a need for updating in all health care aspects, except for “rehabilitation”. “Monitoring and follow-up” as well as “specific forms of angina pectoris” could be included as new aspects in the DMP.

Final report in German is available here.

See full details in German here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.